ArticleImmunoTargets and therapy2025

Durable Tumor Control with Multi-Organ Immune-Related Adverse Events Following Immune Checkpoint Inhibitor and Sequential Radiotherapy in Locally Advanced NSCLC: A Case Report.

Menglan Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.